NSV Partners III LP, 10% Owner at Ventyx Biosciences, Inc. (VTYX), sold 22,217 shares at $37.59 ($835K) on 2023-07-31, disclosed to the SEC on 2023-08-01.
Scheduled sale ($835k) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $37.53 | 611 | $23K | 2.7% |
| 2 | $37.59 | 10,803 | $406K | 48.6% |
| 3 | $37.59 | 10,803 | $406K | 48.6% |
| Total | $37.59 avg | 22,217 | $835K | 100% |
| Filing → |
| VTYX | SELL | 2023-07-06 | $10.5M | — | Filing → |
| VTYX | SELL | 2023-06-16 | $1.8M | — | Filing → |
| VTYX | SELL | 2023-04-25 | $7.7M | — | Filing → |